Literature DB >> 26289010

Is empiric daptomycin effective in reducing mortality in Staphylococcus aureus bacteraemia? A real-life experience.

Matteo Bassetti1,2, Filippo Ansaldi3, Daniela De Florentiis3, Elda Righi4, Federico Pea5, Assunta Sartor6, Claudio Scarparo6, Alessia Carnelutti4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26289010     DOI： 10.1007/s00134-015-4021-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus.

Authors:  Thomas P Lodise; Peggy S McKinnon; Donald P Levine; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2007-07-30       Impact factor: 5.191

2.  Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients.

Authors:  Matteo Bassetti; Giovanni Villa; Filippo Ansaldi; Daniela De Florentiis; Carlo Tascini; Piergiogio Cojutti; Elda Righi; Assunta Sartor; Massimo Crapis; Francesco Giuseppe De Rosa; Federico Pea; Francesco Menichetti
Journal:  Intensive Care Med       Date:  2014-12-02       Impact factor: 17.440

3.  Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study.

Authors:  Carol L Moore; Paola Osaki-Kiyan; Nadia Z Haque; Mary Beth Perri; Susan Donabedian; Marcus J Zervos
Journal:  Clin Infect Dis       Date:  2011-11-21       Impact factor: 9.079

4.  High-dose daptomycin in documented Staphylococcus aureus infections.

Authors:  Matteo Bassetti; Elena Nicco; Francesca Ginocchio; Filippo Ansaldi; Daniela de Florentiis; Claudio Viscoli
Journal:  Int J Antimicrob Agents       Date:  2010-09-16       Impact factor: 5.283

5.  Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia.

Authors:  M Bassetti; E M Trecarichi; A Mesini; T Spanu; D R Giacobbe; M Rossi; E Shenone; G D Pascale; M P Molinari; R Cauda; C Viscoli; M Tumbarello
Journal:  Clin Microbiol Infect       Date:  2011-10-14       Impact factor: 8.067
  5 in total
  1 in total

Review 1.  Bloodstream infections in the Intensive Care Unit.

Authors:  Matteo Bassetti; Elda Righi; Alessia Carnelutti
Journal:  Virulence       Date:  2016-01-13       Impact factor: 5.882
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.